Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy

Tumor Biology

Volumn 36, Issue 8, 2015, Pages 6541-6550

  Enyu, Liu ^a   Zhengchuan, Niu ^a,b   Jiayong, Wang ^a   Benjia, Liang ^a,b   Qi, Sun ^a,b   Ruixi, Qin ^a   Cheng, Peng ^a   Khan, Abdul Qadir ^a   Wei, Song ^c   Jun, Niu ^a  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c General Hospital of Yanzhou Mining Affairs Bureau   (China)

Author keywords

eIF4E; Integrin 6; Protein synthesis; Translation initiation

Indexed keywords

BETA6 INTEGRIN; FIBRONECTIN; FLUOROURACIL; INITIATION FACTOR 4E; MESSENGER RNA; SMALL INTERFERING RNA; ALPHAVBETA6 INTEGRIN; INTEGRIN; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; COLON TUMOR; CONTROLLED STUDY; DRUG RESISTANCE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; TRANSLATION REGULATION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; PATHOLOGY;

ANTIGENS, NEOPLASM; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; INTEGRINS; RNA, MESSENGER;

EID: 84940435673     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3348-8     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.
2. Parsyan A, Hernandez G, Meterissian S. Translation initiation in colorectal cancer. Cancer Metastasis Rev. 2012;31(1–2):387–95. doi:10.1007/s10555-012-9349-9.
3. Ramos DM, Dang D, Sadler S. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Anticancer Res. 2009;29(1):125–30.
4. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005;115(2):339–47. doi:10.1172/JCI23183.
5. Zhang ZY, Xu KS, Wang JS, Yang GY, Wang W, Wang JY, et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin Oncol (R Coll Radiol). 2008;20(1):61–6. doi:10.1016/j.clon.2007.09.008.
6. Niu J, Gu X, Turton J, Meldrum C, Howard EW, Agrez M. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun. 1998;249(1):287–91. doi:10.1006/bbrc.1998.9128.
7. Yang GY, Xu KS, Pan ZQ, Zhang ZY, Mi YT, Wang JS, et al. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci. 2008;99(5):879–87. doi:10.1111/j.1349-7006.2008.00762.x.
8. Zhao-Yang Z, Ke-Sen X, Qing-Si H, Wei-Bo N, Jia-Yong W, Yue-Tang M, et al. Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett. 2008;266(2):209–15. doi:10.1016/j.canlet.2008.02.054.
9. Peng C, Liu X, Liu E, Xu K, Niu W, Chen R, et al. Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway. Cancer Sci. 2009;100(12):2302–8. doi:10.1111/j.1349-7006.2009.01320.x.
10. Niu W, Liu X, Zhang Z, Xu K, Chen R, Liu E, et al. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. Anticancer Res. 2010;30(1):135–42.
11. Liu S, Wang J, Niu W, Liu E, Peng C, Lin P, et al. The beta6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer. Cancer Lett. 2013;328(2):325–34. doi:10.1016/j.canlet.2012.10.004.
12. Niu Z, Wang J, Muhammad S, Niu W, Liu E, Peng C, et al. Protein expression of eIF4E and integrin alphavbeta6 in colon cancer can predict clinical significance, reveal their correlation and imply possible mechanism of interaction. Cell Biosci. 2014;4:23. doi:10.1186/2045-3701-4-23.
13. Yang HY, Xue LY, Xing LX, Wang J, Wang JL, Yan X, et al. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma. Mol Med Rep. 2013;7(2):537–42. doi:10.3892/mmr.2012.1208.
14. Joshi B, Cameron A, Jagus R. Characterization of mammalian eIF4E-family members. Eur J Biochem. 2004;271(11):2189–203. doi:10.1111/j.1432-1033.2004.04149.x.
15. Robalino J, Joshi B, Fahrenkrug SC, Jagus R. Two zebrafish eIF4E family members are differentially expressed and functionally divergent. J Biol Chem. 2004;279(11):10532–41. doi:10.1074/jbc.M313688200.
16. Carroll M, Borden KL. The oncogene eIF4E: using biochemical insights to target cancer. J Interferon Cytokine Res. 2013;33(5):227–38. doi:10.1089/jir.2012.0142.
17. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene. 2004;23(18):3189–99. doi:10.1038/sj.onc.1207545.
18. De Benedetti A, Harris AL. eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol. 1999;31(1):59–72.
19. Raught B, Gingras AC. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol. 1999;31(1):43–57.
20. Sun Q, Sun F, Wang B, Liu S, Niu W, Liu E, et al. Interleukin-8 promotes cell migration through integrin alphavbeta6 upregulation in colorectal cancer. Cancer Lett. 2014;354(2):245–53. doi:10.1016/j.canlet.2014.08.021.
21. Wang B, Wang W, Niu W, Liu E, Liu X, Wang J, et al. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin alphavbeta6. Carcinogenesis. 2014;35(2):282–91. doi:10.1093/carcin/bgt331.
22. Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum CJ, et al. Direct integrin alphavbeta6-ERK binding: implications for tumour growth. Oncogene. 2002;21(9):1370–80. doi:10.1038/sj.onc.1205286.
23. Soni A, Akcakanat A, Singh G, Luyimbazi D, Zheng Y, Kim D, et al. eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling. Mol Cancer Ther. 2008;7(7):1782–8. doi:10.1158/1535-7163.MCT-07-2357.
24. Agrez M, Chen A, Cone RI, Pytela R, Sheppard D. The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain. J Cell Biol. 1994;127(2):547–56.
25. Chen BJ, Wu YL, Tanaka Y, Zhang W. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 2014;10(10):1084–96. doi:10.7150/ijbs.10190.
26. Ito Y, Takeda T, Okada M, Matsuura N. Expression of ets-1 and ets-2 in colonic neoplasms. Anticancer Res. 2002;22(3):1581–4.
27. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer. 2010;10(4):254–66. doi:10.1038/nrc2824.
28. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature. 1990;345(6275):544–7. doi:10.1038/345544a0.
29. Zimmer SG, DeBenedetti A, Graff JR. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res. 2000;20(3A):1343–51.
30. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108(Pt 6):2241–51.
31. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84. doi:10.1038/nrc2622.
32. Wang J, Wu J, Hong J, Chen R, Xu K, Niu W, et al. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin alphavbeta6. Cancer Lett. 2011;311(1):38–47. doi:10.1016/j.canlet.2011.06.025.
33. Gao H, Peng C, Liang B, Shahbaz M, Liu S, Wang B, et al. beta6 integrin induces the expression of metalloproteinase-3 and metalloproteinase-9 in colon cancer cells via ERK-ETS1 pathway. Cancer Lett. 2014;354(2):427–37. doi:10.1016/j.canlet.2014.08.017.
34. Gu X, Niu J, Dorahy DJ, Scott R, Agrez MV. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. Br J Cancer. 2002;87(3):348–51. doi:10.1038/sj.bjc.6600480.
35. Niu J, Dorahy DJ, Gu X, Scott RJ, Draganic B, Ahmed N, et al. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit. Int J Cancer. 2002;99(4):529–37. doi:10.1002/ijc.10397.
36. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science. 1995;268(5208):233–9.
37. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol. 1998;10(2):220–31.
38. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol. 1995;11:549–99. doi:10.1146/annurev.cb.11.110195.003001.
39. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM. Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol. 2002;158(1):165–74. doi:10.1083/jcb.200112015.
40. Pabla R, Weyrich AS, Dixon DA, Bray PF, McIntyre TM, Prescott SM, et al. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol. 1999;144(1):175–84.
41. Gorrini C, Loreni F, Gandin V, Sala LA, Sonenberg N, Marchisio PC, et al. Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways. Proc Natl Acad Sci U S A. 2005;102(26):9200–5. doi:10.1073/pnas.0409513102.
42. Chung J, Kim TH. Integrin-dependent translational control: implication in cancer progression. Microsc Res Tech. 2008;71(5):380–6. doi:10.1002/jemt.20566.
43. Populo H, Lopes JM, Soares P. The mTOR Signalling pathway in human cancer. Int J Mol Sci. 2012;13(2):1886–918. doi:10.3390/ijms13021886.
44. Ye Q, Cai W, Zheng Y, Evers BM, She QB. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene. 2014;33(14):1828–39. doi:10.1038/onc.2013.122.